Evidence map›Paper›PMID 29472605›Full record

ArticleScientific reports2018

DEHP deregulates adipokine levels and impairs fatty acid storage in human SGBS-adipocytes.

Kristina Schaedlich, Scarlett Gebauer, Luise Hunger, Laura-Sophie Beier, Holger M Koch, Martin Wabitsch, Bernd Fischer, Jana Ernst

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Obesogens: a unifying theory for the global rise in obesity.International journal of obesity (2005) · 2024
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kristina SchaedlichDepartment of Anatomy and Cell Biology, Martin Luther University, Faculty of Medicine, Grosse Steinstrasse 52, D-06097, Halle (Saale), Germany. kristina.schaedlich@medizin.uni-halle.de.ORCID 0000-0003-4465-5087
Scarlett GebauerDepartment of Anatomy and Cell Biology, Martin Luther University, Faculty of Medicine, Grosse Steinstrasse 52, D-06097, Halle (Saale), Germany.
Luise HungerDepartment of Anatomy and Cell Biology, Martin Luther University, Faculty of Medicine, Grosse Steinstrasse 52, D-06097, Halle (Saale), Germany.
Laura-Sophie BeierDepartment of Anatomy and Cell Biology, Martin Luther University, Faculty of Medicine, Grosse Steinstrasse 52, D-06097, Halle (Saale), Germany.
Holger M KochInstitute for Prevention and Occupational Medicine of the German Social Accident Insurance - Institute of the Ruhr-University Bochum (IPA), Bürkle-de-la-Camp-Platz 1, D- 44789, Bochum, Germany.
Martin WabitschDepartment of Pediatrics and Adolescent Medicine, Division of Pediatric Endocrinology and Diabetes Ulm, Eythstrasse 24, D-89075, Ulm, Germany.
Bernd FischerDepartment of Anatomy and Cell Biology, Martin Luther University, Faculty of Medicine, Grosse Steinstrasse 52, D-06097, Halle (Saale), Germany.
Jana ErnstDepartment of Anatomy and Cell Biology, Martin Luther University, Faculty of Medicine, Grosse Steinstrasse 52, D-06097, Halle (Saale), Germany.
Martin Luther University Halle-Wittenberg · DEIDT Biologika (Germany) · DEInstitute for Prevention and Occupational Medicine · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DEHP is a plasticizer which has been used in plastic products of everyday use for decades. Studies in mice and murine cell culture models identified DEHP as an endocrine disruptor that may also act as an obesogen. As this is of high concern in respect of the worldwide obesity epidemic, our aim is the translation of these findings into a human model system. On the basis of DOHaD, we investigated the influence of an environmentally relevant dose of DEHP [50 µg/ml] on adipogenesis in the human cell culture model SGBS. Pre-adipocytes were exposed to DEHP and differentiated into mature adipocytes. At different stages of differentiation, markers of adipogenesis like GLUT4, FABP4, LPL and PPARs, and of signaling pathways like AMPK/ACC2, JAK/STAT and MAPK were analyzed. Functional markers like adipokine secretion and triglyceride content as well as ROS production were measured in mature adipocytes. We found significantly lower expression levels of adipogenic markers, a reduction in lipid accumulation, higher leptin- and reduced adiponectin levels in the supernatant of treated adipocytes. Moreover, ROS production was significantly elevated after DEHP-exposure. In conclusion, DEHP led to lower grade of adipogenic differentiation in human SGBS-adipocytes under the chosen conditions.

Indexed as

AdipocytesAdipogenesisAdiponectinArrhythmias, CardiacCells, CulturedDiethylhexyl PhthalateFatty AcidsGenetic Diseases, X-LinkedGigantismHeart Defects, CongenitalHumansIntellectual DisabilityLeptinPlasticizersReactive Oxygen SpeciesTriglyceridesAdiponectinDiethylhexyl PhthalateFatty AcidsLeptinPlasticizersReactive Oxygen SpeciesTriglycerides

Identifiers

PMID29472605
PMCPMC5823900
OpenAlexW2807537802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.